Thermo Fisher Scientific Inc Common Stock (TMO) stock analysis

TMO · Thermo Fisher Scientific Inc Common Stock

Latest recorded price: USD 691.33

Model-estimated fair value: USD 185.46. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Diagnostics & Research

At $691.33, TMO trades 272.8% above the model's base-case value of $185.46. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $133.14 in the conservative case and $241.81 in the optimistic case, with a valuation confidence score of 75/100. About 72% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth -0.3%, free cash flow margin 14.1%, ROIC 6.9%. The model flags 1 risk signal for this company.

Similar companies in Healthcare